Silymarin (milk thistle)

What is this medication for?

• Adjunctive therapy of chronic liver disease; hepatic recovery/regeneration support; fibrosis; ameliorating anticonvulsant liver damage

How is it given?

Give exactly as your veterinarian prescribed — never change the dose or stop on your own unless your veterinarian has told you to.

What if I miss a dose?

• Give it as soon as you remember — unless it is almost time for the next dose (then skip the missed one; never double up).
• Call your clinic if you miss more than one dose in a row.

Side effects — what should I watch for?

Effects listed as common in this handout

• Generally well tolerated
• Occasional stomach/intestinal upset (nausea→diarrhea) (Human-reported)
• Allergic reactions (Asteraceae/Compositae allergy (ragweed, marigold, daisy))

Worth a phone call to your veterinarian

• Any new symptom that worries you.

⚠️ Contact your veterinarian or an emergency clinic IMMEDIATELY if you notice

• Trouble breathing, collapse, seizures, severe vomiting or diarrhea, facial swelling, or pale gums

Before starting (or refilling), tell your veterinarian if your pet:

• has or has had: Plant-part extracts (not seed extracts) may have estrogen-like activity — avoid where estrogens contraindicated. Do not confuse with Blessed Thistle (different plant)

• is pregnant, nursing, or used for breeding
• is taking any other medications, supplements, or flea/tick products, including:
  • CYP2C9 substrates (warfarin, amitriptyline, verapamil)
  • Glucuronidated drugs (acetaminophen, diazepam, morphine)

Storage and handling

Room temperature, tight containers, low humidity. Buy products stating silymarin concentration (70–80%) — unregulated supplement market.

Good to know

• Mechanism basket: free-radical scavenging, ↑ hepatic glutathione, anti-TNF/anti-apoptotic effects, altered hepatocyte membranes blocking toxin entry, ↓ collagen (anti-fibrotic).
• Silibinin is the most active of the four flavolignans — complexed products (e.g., Marin) beat raw milk thistle powder for absorption.
• Evidence is adjunctive-level; pair with definitive therapy (ursodiol, immunosuppression, copper management) rather than as a lone agent.